After The Stock Rose 12.57% Over The Week, Is 4D Molecular Therapeutics Inc (NASDAQ: FDMT) Still A Buy?
4D Molecular Therapeutics Inc (NASDAQ:FDMT)’s traded shares stood at 0.48 million during the last session, with the company’s beta value hitting 2.86. At the close